Expertise-driven CRISPR gene editing service to reorganize plant genomes into tandem expressed gene pairs, enabling targeted manipulation of secondary metabolism pathways in crop plants. Led by a lab with 35+ years of genetic engineering experience and active CRISPR-edited plant lines under evaluation.
This offering provides expert CRISPR-based genomic reorganization capabilities for crop plants, with a focus on creating tandem expressed gene pairs to manipulate secondary metabolism. The laboratory brings decades of genetic engineering experience to design guide RNAs, identify transgenes, and execute precision genome edits tailored to the target plant species. The approach is adaptable across plant systems and is informed by ongoing evaluation of CRISPR-edited plants for gene expression differences.
The laboratory is actively conducting basic research with CRISPR-edited plants currently under evaluation for gene expression differences. The core competencies in guide RNA design, transgene identification, and genetic engineering are well established through decades of prior work. Future validation steps depend on the specific gene targets and genomic architecture of the plant system of interest, meaning the readiness level is best characterized as early-stage research with proven enabling expertise ready to be applied to new targets.
The University of Virginia is a comprehensive public research university with broad academic programs and a robust research enterprise. Integration with UVA Health enables clinical translation, large-scale trials, and data-driven care in an academic medical setting. A university-operated discovery park, North Fork—A UVA Discovery Park, co-locates companies with faculty and government partners, while participation in the Commonwealth Center for Advanced Manufacturing gives access to production-scale testbeds and joint industry projects. Research is supported by competitive federal funding, including NIH, NSF, DOE, and DoD. The Licensing & Ventures Group manages IP, licensing, and startup formation to speed commercialization.